Research · MIT Technology Review ·
Closing the data loop in AI-driven drug discovery
AI-driven drug discovery is being developed amid rising costs, increasing competition for first-mover advantage, and development timelines of 10–15 years. The sector faces Eroom’s Law, under which the cost of developing medicines has roughly doubled every nine years since the 1950s.